Pdl Biopharma Inc (PDLI)

SG&A Expense Growth

-100.00%

Quarterly · Period ending:

PDLI logo

PDLI SG&A Expense Growth

Latest reported-100.00%
PDLI Quarterly SG&A Growth (QoQ) (0.00% → -100.00%)
High-resolution chart · PNG

PDLI sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-100%
-22.4024%
-2.8153%
5.2449%
9.9395%
-4.8211%
50.0626%
-47.2962%
-16.2398%
15.9543%
5.5108%
-4.1571%
13.9493%
-1.6887%
15.5136%
26.1074%
49.7195%
-29.4028%
-21.5145%
48.4615%
13.7434%
-3.0916%
-56.7528%
211.7482%
-17.8324%
51.0258%
-41.7123%
-0.8076%
16.8362%
-5.6081%
-7.0616%
36.9223%
9.757%
-12.5892%
38.919%
23.1686%
5.4891%
-38.1566%
-94.9568%
841.0981%
25.9637%
-6.2699%
70.2859%
5.157%
-5.9928%
19.1136%
-70.6688%
-13.7234%
10.092%
165.5269%
-153.6479%
19.1723%
7.9871%
-1.8608%
-65.1223%
284.0123%
7.9738%
-18.4179%
-27.1811%
5.1%
112.1579%
158.3616%
-11.1085%
12.5261%
2.8725%
-7.6599%
-10.2958%
34.319%
-8.9351%
45.0296%
-6.3193%
14.2978%
-1.1276%
15.2033%
-3.7286%
15.5782%
-7.7986%
11.9337%
-28.922%
28.8389%
0%
19.4621%
0.2727%
0%
-2.9412%
3.0303%
-13.1579%
22.5806%
6.8966%
11.5385%
-3.7037%
12.5%
0%
4.3478%
-4.1667%
9.0909%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.